Skip to content
  1. Home/
  2. Latest news/
  3. Health & wellness/
  4. Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

Psyched about the eclipse? What you need to know to protect your eyes and watch it safely

On August 21, the U.S. will witness the first total eclipse of the sun in 40 years. In this video, get tips from a Johnson & Johnson expert on how to safeguard your eyes—and enjoy the one-of-a-kind celestial event.

On Monday, August 21, a total eclipse of the sun will be visible in parts of the continental U.S. for the first time in almost 40 years as the moon completely covers it—and observers in all states will experience at least a partial eclipse.

Because this phenomenon is so rare—the next total eclipse won’t occur in the U.S. until 2024—Americans across the country are clamoring to watch. And there’s no reason not to—as long as you do so safely: Even when blocked by the moon, the sun’s rays, both visible and invisible, can cause severe and permanent damage to the eyes.

So before you check out the eclipse, check out this video—featuring safe viewing tips from Johnson & Johnson Vision ultraviolet expert Cristina Schnider, O.D.


1775614113001-5544058705001-5544061612001-vs.jpg
Eclipse_v6

More from Johnson & Johnson

“The surgical devices I design for Johnson & Johnson can help speed healing and save lives”

Candice Otrembiak’s work combines her love of science with her natural problem-solving skills. The result: high-tech devices that help make medical procedures more efficient for surgeons and safer for patients.

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

What you need to know about Johnson & Johnson’s 2024 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and full-year performance, with highlights from its Innovative Medicine and MedTech businesses.